4-chloro-N-(2-((5-trifluoromethyl-2-pyridyl)sulfonyl)ethyl)benzamide

peroxisome proliferator activated receptor delta ; Homo sapiens







6 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33377581 Dexmedetomidine protects cardiac microvascular endothelial cells from the damage of ogd/r through regulation of the pparδ-mediated autophagy. 2021 May 1
2 30982495 PPARβ/δ Agonist GW501516 Inhibits Tumorigenesis and Promotes Apoptosis of the Undifferentiated Nasopharyngeal Carcinoma C666-1 Cells by Regulating miR-206. 2019 Aug 8 1
3 26707845 Synthesis of 5-trifluoromethyl-2-sulfonylpyridine PPARβ/δ antagonists: Effects on the affinity and selectivity towards PPARβ/δ. 2016 Jan 15 3
4 26964143 PPARβ/δ directs the therapeutic potential of mesenchymal stem cells in arthritis. 2016 Dec 1
5 24508264 Palmitic acid suppresses apolipoprotein M gene expression via the pathway of PPARβ/δ in HepG2 cells. 2014 Feb 28 1
6 20128594 Identification and characterization of 4-chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a selective and irreversible peroxisome proliferator-activated receptor delta (PPARdelta) antagonist. 2010 Feb 25 5